Aug 21, 2026 04:35PM
Aug 4, 2026 08:01AM
Apr 7, 2026 08:07AM
Mar 26, 2026 08:02AM
Mar 16, 2026 08:02AM
Nov 19, 2025 08:01AM
May 29, 2025 08:04AM Alzamend Neuro (ALZN) Announces Dosing of First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital
May 19, 2025 08:03AM
May 8, 2025 08:01AM
Mar 27, 2025 04:35PM
Mar 4, 2025 08:11AM
Feb 19, 2025 08:04AM
Nov 19, 2024 08:02AM
Oct 16, 2024 08:06AM Alzamend Neuro (ALZN) Announces Full Data Set from Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s
Oct 15, 2024 08:04AM
Aug 26, 2024 08:04AM
Aug 19, 2024 10:03AM
Aug 19, 2024 08:06AM
Aug 12, 2024 08:03AM
Aug 5, 2024 09:10AM
Jul 31, 2024 08:00AM Alzamend Neuro (ALZN) Regains Nasdaq Compliance
Jul 12, 2024 08:00AM
Jun 26, 2024 04:48PM

445,682 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All